Take Your Trading To The Next Level. Get Started Here!

More convenient form of breakthrough Alzheimer’s drug Leqembi shows promising results in study

October 25, 2023 Comments Off

Eisai and Biogen said in a release that they plan to apply for U.S. approval of subcutaneous Leqembi by the end of March.